208 related articles for article (PubMed ID: 29150436)
1. Microvesicles derived from human Wharton's Jelly mesenchymal stem cells ameliorate ischemia-reperfusion-induced renal fibrosis by releasing from G2/M cell cycle arrest.
Chen W; Yan Y; Song C; Ding Y; Du T
Biochem J; 2017 Dec; 474(24):4207-4218. PubMed ID: 29150436
[TBL] [Abstract][Full Text] [Related]
2. Micro-vesicles derived from human Wharton's Jelly mesenchymal stromal cells mitigate renal ischemia-reperfusion injury in rats after cardiac death renal transplantation.
Wu X; Yan T; Wang Z; Wu X; Cao G; Zhang C; Tian X; Wang J
J Cell Biochem; 2018 Feb; 119(2):1879-1888. PubMed ID: 28815768
[TBL] [Abstract][Full Text] [Related]
3. Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1.
Zou X; Zhang G; Cheng Z; Yin D; Du T; Ju G; Miao S; Liu G; Lu M; Zhu Y
Stem Cell Res Ther; 2014 Mar; 5(2):40. PubMed ID: 24646750
[TBL] [Abstract][Full Text] [Related]
4. The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism.
Du T; Cheng J; Zhong L; Zhao XF; Zhu J; Zhu YJ; Liu GH
Cytotherapy; 2012 Nov; 14(10):1215-27. PubMed ID: 22920838
[TBL] [Abstract][Full Text] [Related]
5. The anti-oxidative role of micro-vesicles derived from human Wharton-Jelly mesenchymal stromal cells through NOX2/gp91(phox) suppression in alleviating renal ischemia-reperfusion injury in rats.
Zhang G; Zou X; Miao S; Chen J; Du T; Zhong L; Ju G; Liu G; Zhu Y
PLoS One; 2014; 9(3):e92129. PubMed ID: 24637475
[TBL] [Abstract][Full Text] [Related]
6. Microvesicles derived from human umbilical cord mesenchyme promote M2 macrophage polarization and ameliorate renal fibrosis following partial nephrectomy via hepatocyte growth factor.
Du T; Ju G; Zhou J; Zhong L; Rong L; Chen W; Zhang X; Zhou R; Ding D; Ji T
Hum Cell; 2021 Jul; 34(4):1103-1113. PubMed ID: 33860459
[TBL] [Abstract][Full Text] [Related]
7. Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells.
Du T; Zou X; Cheng J; Wu S; Zhong L; Ju G; Zhu J; Liu G; Zhu Y; Xia S
Stem Cell Res Ther; 2013 Jun; 4(3):59. PubMed ID: 23734757
[TBL] [Abstract][Full Text] [Related]
8. Microvesicles derived from human Wharton's Jelly mesenchymal stem cells ameliorate acute lung injury partly mediated by hepatocyte growth factor.
Chen W; Wang S; Xiang H; Liu J; Zhang Y; Zhou S; Du T; Shan L
Int J Biochem Cell Biol; 2019 Jul; 112():114-122. PubMed ID: 31100425
[TBL] [Abstract][Full Text] [Related]
9. Microvesicles derived from human umbilical cord Wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo.
Wu S; Ju GQ; Du T; Zhu YJ; Liu GH
PLoS One; 2013; 8(4):e61366. PubMed ID: 23593475
[TBL] [Abstract][Full Text] [Related]
10. Microvesicles derived from human Wharton's jelly mesenchymal stem cells promote human renal cancer cell growth and aggressiveness through induction of hepatocyte growth factor.
Du T; Ju G; Wu S; Cheng Z; Cheng J; Zou X; Zhang G; Miao S; Liu G; Zhu Y
PLoS One; 2014; 9(5):e96836. PubMed ID: 24797571
[TBL] [Abstract][Full Text] [Related]
11. Microvesicles derived from human umbilical cord mesenchymal stem cells facilitate tubular epithelial cell dedifferentiation and growth via hepatocyte growth factor induction.
Ju GQ; Cheng J; Zhong L; Wu S; Zou XY; Zhang GY; Gu D; Miao S; Zhu YJ; Sun J; Du T
PLoS One; 2015; 10(3):e0121534. PubMed ID: 25793303
[TBL] [Abstract][Full Text] [Related]
12. Immune characterization of mesenchymal stem cells in human umbilical cord Wharton's jelly and derived cartilage cells.
Liu S; Yuan M; Hou K; Zhang L; Zheng X; Zhao B; Sui X; Xu W; Lu S; Guo Q
Cell Immunol; 2012; 278(1-2):35-44. PubMed ID: 23121974
[TBL] [Abstract][Full Text] [Related]
13. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.
Gatti S; Bruno S; Deregibus MC; Sordi A; Cantaluppi V; Tetta C; Camussi G
Nephrol Dial Transplant; 2011 May; 26(5):1474-83. PubMed ID: 21324974
[TBL] [Abstract][Full Text] [Related]
14. Microvesicles derived from human umbilical cord mesenchymal stem cells ameliorate renal ischemia-reperfusion injury via delivery of miR-21.
Du T; Zhou J; Chen WX; Zhang XL; Ji TY; Liu J; Rong L; Wang LD; Zhou RJ; Ding DG
Cell Cycle; 2020 Jun; 19(11):1285-1297. PubMed ID: 32329653
[TBL] [Abstract][Full Text] [Related]
15. Microvesicles derived from human Wharton's jelly mesenchymal stem cells enhance autophagy and ameliorate acute lung injury via delivery of miR-100.
Chen WX; Zhou J; Zhou SS; Zhang YD; Ji TY; Zhang XL; Wang SM; Du T; Ding DG
Stem Cell Res Ther; 2020 Mar; 11(1):113. PubMed ID: 32169098
[TBL] [Abstract][Full Text] [Related]
16. Endothelial Progenitor Cells Derived From Wharton's Jelly of Human Umbilical Cord Attenuate Ischemic Acute Kidney Injury by Increasing Vascularization and Decreasing Apoptosis, Inflammation, and Fibrosis.
Liang CJ; Shen WC; Chang FB; Wu VC; Wang SH; Young GH; Tsai JS; Tseng YC; Peng YS; Chen YL
Cell Transplant; 2015; 24(7):1363-77. PubMed ID: 24819279
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury.
Chen Y; Qian H; Zhu W; Zhang X; Yan Y; Ye S; Peng X; Li W; Xu W
Stem Cells Dev; 2011 Jan; 20(1):103-13. PubMed ID: 20446811
[TBL] [Abstract][Full Text] [Related]
18. Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease.
Wang Y; Lu X; He J; Zhao W
Stem Cell Res Ther; 2015 May; 6(1):100. PubMed ID: 25998259
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells microvesicles stabilize endothelial barrier function partly mediated by hepatocyte growth factor (HGF).
Wang H; Zheng R; Chen Q; Shao J; Yu J; Hu S
Stem Cell Res Ther; 2017 Sep; 8(1):211. PubMed ID: 28969681
[TBL] [Abstract][Full Text] [Related]
20. Activation of ERK accelerates repair of renal tubular epithelial cells, whereas it inhibits progression of fibrosis following ischemia/reperfusion injury.
Jang HS; Han SJ; Kim JI; Lee S; Lipschutz JH; Park KM
Biochim Biophys Acta; 2013 Dec; 1832(12):1998-2008. PubMed ID: 23851027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
